Auger Anick (@AnickOG) profile picture

Auger Anick

@AnickOG

Scientifique et maman passionnée qui ESSAI de faire en sorte que chaque moment compte / Scientist and passionate mom who TRIES to make every moment count

 Montréal, Québec
ventustx.com
Joined September 2012
  • Tweets464
  • Following160
  • Followers55
23Media
Photo by Auger Anick (@AnickOG)Photo by Auger Anick (@AnickOG)Photo by Auger Anick (@AnickOG)Photo by Auger Anick (@AnickOG)Photo by Auger Anick (@AnickOG)Photo by Auger Anick (@AnickOG)Photo by Auger Anick (@AnickOG)Photo by Auger Anick (@AnickOG)Photo by Auger Anick (@AnickOG)Photo by Auger Anick (@AnickOG)
🎉 Congratulations to Marcelo Bigal and the team at Ventus Therapeutics, a resident company at the adMare Montreal Innovation Centre, for being named a “Fierce 15” company in Fierce Biotech’s 2023 annual report. Learn more ➡ ventustx.com/ventus-therapeu…
Image from adMare BioInnovations (@adMare_Bio)
1
7
355
Interesting! Low dose colchicine – the microtubule disrupter that inhibits NLRP3 – has been approved for cardiovascular (CV) disease treatment, a proof of principle for targeting NLRP3 in CV diseases, medscape.com/viewarticle/993… – at Brookline, MA
FDA OKs Low-Dose Colchicine for Broad CV Indication

FDA OKs Low-Dose Colchicine for Broad CV Indication

The drug represents the first specific anti-inflammatory drug for the reduction of cardiovascular events for patients with established atherosclerotic disease or with multiple risk factors.

medscape.com
2
6
1
39
3,999
Me and my colleagues ran for the cause today! #OutrunPD #GoTeamFox
Image from Auger Anick (@AnickOG)
1
5
379
Another exciting news!
This Post is from an account that no longer exists. Learn more
1
If you are interested about Science, listen to this podcast. @Ventus_Tx
Jason Burch (@DrBanjoCrush) profile pictureJason Burch@DrBanjoCrush8 Oct 2022
If you want to learn about what we are up to at ⁦@Ventus_Tx⁩ and the journey our CEO Marcelo Bigal made to get to our company check out this great podcast. podcasts.apple.com/ca/podcas…
The Magic of Drug Development

The Magic of Drug Development

Podcast Episode · Molecule to Market: Inside the outsourcing space · September 29, 2022 · 53m

podcasts.apple.com
Very exciting day! #NLRP3 #innateimmunity #metabolicdiseases
This Post is from an account that no longer exists. Learn more
5
#NLRP3 #Ventustx
This Post is from an account that no longer exists. Learn more
3
Jedi Dan McKay I love it! #Ventus_tx #hiring #compchem
This quoted post is unavailable.
Try viewing anyway · View on X
1
3
Another exciting news about @Ventus_Tx
This Post is from an account that no longer exists. Learn more
2
#Bellcause
Dany Turcotte (@danytrcotte) profile pictureDany Turcotte@danytrcotte26 Jan 2022
La chose 🦠a fait des ravages dans nos cerveaux 🧠! La campagne #Bellcause est encore plus essentielle cette année! Retweetons à grands coups de 5 cents!
La santé mentale est encore plus fragile avec cette pandémie #BellCause
1
Tellement!!!
This Post is from an account that no longer exists. Learn more
#GoHabsGo
Image from Auger Anick (@AnickOG)
1
#OutrunPD #GoTeamFox
This Post is from an account that no longer exists. Learn more
1
Watch the latest video featuring my colleague and friend @DrBanjoCrush who describe why it is exciting to be a medicinal chemist at @Ventus_Tx ! #PowerOfResolution
This Post is from an account that no longer exists. Learn more
You think you know everything about water? Watch this new video featuring another of my amazing colleague Dan McKay who taught me that water is not H2O (!) and Tom Kurtzman one of our advisor and leader in the field of computational chemistry! @Ventus_Tx
This Post is from an account that no longer exists. Learn more
2
Want to know what other targets #ventus_tx has in its pipeline other than #NLRP3? Watch this new video featuring our Director of Immunology and Scientific Affairs Kelly A. Pike and another of our amazing founders Thomas Tuschl!
This Post is from an account that no longer exists. Learn more
2
Yesterday was an exciting day for Ventus Therapeutics ! We, for the first time, publicly shared the advances that have allowed us to identify and advance novel #nlrp3 inhibitors. Didn't attend the #EMBOinflammasomes conference? Find out all the details in this press release!
This Post is from an account that no longer exists. Learn more
5
Check out part 2 of our #BeneathTheSurface video series now featuring another amazing founder of @Ventus_Tx @WuLabHarvard and our CSO Michael Crackower. Great complement to my Friday talk at the #EMBOinflammasomes workshop!
This Post is from an account that no longer exists. Learn more
2
I wish I was in Munich to be able to discuss more easily with all the NLRP3 world leaders that are attending the #EMBOInflammasome workshop. Looking forward to my talk on Friday! #ventus_tx #nlrp3 #PowerOfResolution
This Post is from an account that no longer exists. Learn more
5
Load more